.jpg)
.jpg)
.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechn...
Basel, March 28, 2025 – Novartis announced today that the US Food and Drug Admin...
A rival bidder has emerged to acquire struggling gene therapy specialist bluebir...
President Trump again turns to Fox News talent, nominating reporter Sara Carter ...
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for ...
Pluvicto can now be used before chemotherapy to treat a kind of metastatic prost...
The new bid surpasses an offer SK Capital and Carlyle Group made last month for ...
Utah has become the first state to ban fluoride in public drinking water, despit...
Amgen had argued the board is unconstitutional because its actions conflict with...
The federal government is cutting 3,500 full-time FDA employees and 1,200 NIH wo...
Lyndra Therapeutics, which spun out of Moderna co-founder Robert Langer’s lab at...
According to the FDA’s public database, since the start of this year the agency ...
Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. The ...
As the college basketball March Madness tournament gets underway, so too does Fi...
Candel Therapeutics has identified a subpopulation of lung cancer patients livin...
BARDA is being shifted into a new Office of Healthy Futures within HHS, two sour...
At least five states have active measles outbreaks as of Friday, and Texas' is t...
The FDA bends its new return to office policy, acknowledging that pantries and c...
Earlier this month, Ian Lipkin, M.D., and his team at Columbia University submit...
Over the last three years, the FDA has approved six new drugs for hemophilia. An...
After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, open...
Pharma Marketing in 2025: A Conversation with Fierce Pharma
Today, the U.S. Food and Drug Administration approved a novel treatment for hemo...